Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-10-04
1978-01-10
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2602948F, 2602948G, 2602949, 260296R, A61K 31395, C07D21384
Patent
active
040679845
ABSTRACT:
The compounds are ethylene derivatives which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A compound of this invention is 1-nitro-2-methylamino-2-[4-(3-chloro-2-pyridyl)butylamino]ethylene.
REFERENCES:
patent: 3734924 (1973-05-01), Black et al.
patent: 3736331 (1973-05-01), Black et al.
patent: 3808336 (1974-04-01), Durant et al.
patent: 3876647 (1975-04-01), Durant et al.
patent: 3905984 (1975-09-01), Durant et al.
patent: 3920822 (1975-11-01), Durant et al.
Durant Graham John
Emmett John Colin
Ganellin Charon Robin
Prain Hunter Douglas
Edgerton William H.
Foggio Richard D.
Keps Joan S.
Rotman Alan L.
Smith Kline & French Laboratories Limited
LandOfFree
Pyridylbutylamino ethylene compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridylbutylamino ethylene compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridylbutylamino ethylene compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2271492